Blockskye | $15,800,000 | (Jul 18, 2025)
Occupi | $3,000,000 | (Jul 18, 2025)
Receive | $4,000,000 | (Jul 18, 2025)
Certified by Founder
Lodge
ARTBIO
start up
United States
- Cambridge, Massachusetts
- 08/12/2023
- Series A
- $90,000,000
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
- Industry Biotechnology Research
- Website https://artbio.com/
- LinkedIn https://www.linkedin.com/company/artbio-inc/
Related People
Emanuele OstuniFounder
Switzerland -
Reinach, Basel-Country
Specialties: Commercial execution, Strategy, M&A, Business Development, Entrepreneurship,
Empirical Security | $12,000,000 | (Jul 18, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)
StrongestLayer | $5,200,000 | (Jul 18, 2025)
Folio | $14,000,000 | (Jul 18, 2025)
Lo Foods | $3,500,000 | (Jul 18, 2025)
BQP(US) | $5,000,000 | (Jul 18, 2025)
TRIFFT Loyalty | $550,000 | (Jul 18, 2025)
One Biosciences | $17,382,375 | (Jul 17, 2025)
KNOT(INDIA) | $3,000,000 | (Jul 17, 2025)